A detailed history of Eldridge Investment Advisors, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Eldridge Investment Advisors, Inc. holds 705 shares of TMO stock, worth $374,961. This represents 0.11% of its overall portfolio holdings.

Number of Shares
705
Previous 698 1.0%
Holding current value
$374,961
Previous $371,000 10.51%
% of portfolio
0.11%
Previous 0.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$528.82 - $599.43 $3,701 - $4,196
7 Added 1.0%
705 $410,000
Q3 2023

Nov 06, 2023

SELL
$498.29 - $574.41 $39,863 - $45,952
-80 Reduced 10.28%
698 $353,000
Q4 2022

Feb 03, 2023

BUY
$484.71 - $571.37 $24,235 - $28,568
50 Added 6.87%
778 $428,000
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $2,158 - $2,649
-6 Reduced 0.82%
728 $321,000
Q2 2020

Aug 07, 2020

BUY
$275.2 - $362.34 $1,651 - $2,174
6 Added 0.82%
734 $266,000
Q2 2019

Jul 29, 2019

BUY
$257.51 - $295.55 $187,467 - $215,160
728 New
728 $214,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $208B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Eldridge Investment Advisors, Inc. Portfolio

Follow Eldridge Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eldridge Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eldridge Investment Advisors, Inc. with notifications on news.